3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
8
Sarcopenia
2
Prostatic Neoplasms
2
Obesity
2
Melanoma
2
Malnutrition
2
Colorectal Neoplasms
2
Breast Carcinoma In Situ
2
Wound Infection
1
Weight Loss
1
Surgical Wound Infection
1
Skin Neoplasms
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Paget's Disease, Mammary
1
Osteoarthritis
1
Olfaction Disorders
1
Neoplasms
1
Neoplasm, Residual
1
Mandibular Neoplasms
1
Lymphoma, Follicular
1
Lipid Metabolism Disorders
1
Huntington Disease
1
Fatigue
1
Diabetes Mellitus
1
Interventions
Aspirin
4
Blood Pressure
3
Vitamin E
2
Vitamin D
2
Nutrition Assessment
2
Metformin
2
Geritol
2
Diet, Mediterranean
2
Cholecalciferol
2
phosphoribosylformylglycinamidine synthetase
1
glycidol
1
ficlatuzumab
1
beta Carotene
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Vascular Stiffness
1
Tumor Necrosis Factor Inhibitors
1
Therapeutics
1
Sugars
1
Spironolactone
1
Resistance Training
1
Raloxifene Hydrochloride
1
Pulse Wave Analysis
1
Progestins
1
Physical Conditioning, Human
1
Omeprazole
1
Noninvasive Prenatal Testing
1
Naproxen
1
Methods
1
Lysine Acetyltransferase 5
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiovascular Diseases
×
Docosahexaenoic Acids
×
Clear all
NCT04116203
2025-02-28
PCOS
University of Alberta
Phase 1
Completed
52 enrolled